Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan 24;2007(1):CD003163.
doi: 10.1002/14651858.CD003163.pub4.

Topical nasal steroids for intermittent and persistent allergic rhinitis in children

J J Al Sayyad  1 , Z Fedorowicz, D Alhashimi, A Jamal
Affiliations

Topical nasal steroids for intermittent and persistent allergic rhinitis in children

J J Al Sayyad et al. Cochrane Database Syst Rev. .

Abstract

Background: Allergic rhinitis is a very common chronic illness affecting 10% to 40% of children worldwide. There has been a significant increase in prevalence among children over the last two decades and this increase has been accompanied by a parallel increase in comorbid illnesses such as asthma.

Objectives: To evaluate the therapeutic effectiveness and adverse event profiles of topical nasal steroids for intermittent and persistent allergic rhinitis in children.

Search strategy: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 3, 2005), MEDLINE (1950 onwards) and EMBASE (1974 onwards) on 5(th) September 2005. CINAHL, mRCT(a meta-database of controlled trials), NRR (the National Research Register), LILACS, MedCarib, KOREAMED, IndMed, Samed, Panteleimon, Zetoc, ISI Proceedings, the GlaxoSmithKline Clinical Trials Database and the websites of AstraZeneca, Schering Plough and Aventis were also searched.

Selection criteria: Randomised controlled trials comparing topical nasal steroid preparations against each other or placebo, prescribed for allergic rhinitis in children.

Data collection and analysis: Two authors independently assessed trial quality and extracted data from the included trials. The limited and variable quality of reported data precluded any pooling of results and only a descriptive summary is presented.

Main results: Three trials involving a total of 79 participants were included. All three trials, which compared topical nasal steroids against placebo for perennial rhinitis, provided some, albeit limited data, relevant to our primary outcomes; but in two of the trials the data analysis was flawed and in the third trial it was incomprehensible. None of the trials provided data relevant to our secondary outcomes. There were no adverse events reported from any of the interventions.

Authors' conclusions: The three included trials provided some weak and unreliable evidence for the effectiveness of Beconase(R) and flunisolide used topically intranasally for the treatment of intermittent and persistent allergic rhinitis in children. The reduction of severity in symptoms as assessed by the trialists could not be confirmed with the data provided and decisions on the use of these medications should, until such time as more robust evidence is available, be guided by the physician's clinical experience and patients' individual circumstances and preferences.

PubMed Disclaimer

Conflict of interest statement

There are no financial conflicts of interest and the reviewers declare that they do not have any association with any manufacturers or promoters of pharmaceutical products or any parties who may have vested interests in the results of this review.

Update of

  • doi: 10.1002/14651858.CD003163.pub3

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Hill 1978 {published data only}
    1. Hill D, Connelly D, Vorath J. Beclomethasone dipropionate aerosol in the treatment of children with severe perennial rhinitis. Medical Journal of Australia 1978;2(13):603‐4. - PubMed
Neuman 1978 {published data only}
    1. Neuman I, Toshner D. Beclomethasone dipropionate in pediatric perennial extrinsic rhinitis. Annals of Allergy 1978;40(5):346‐8. - PubMed
Sarsfield 1979 {published data only}
    1. Sarsfield JK, Thomson GE. Flunisolide nasal spray for perennial rhinitis in children. British Medical Journal 1979;2(6182):95‐7. - PMC - PubMed

References to studies excluded from this review

Agertoft 1993 {published data only}
    1. Agertoft L, Wolthers OD, Fuglsang G, Pedersen S. Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents. Pediatric Allergy and Immunology 1993;4(3):152‐6. - PubMed
Andersson 1995 {published data only}
    1. Andersson M, Berglund R, Greiff L, Hammarlund A, Hedbys L, Malcus I, Nilsson P, Olsson P, Sjolin IL, Synnerstad B. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis. Rhinology 1995;33(1):18‐21. - PubMed
Anon 1980 {published data only}
    1. Anonymous. Double‐blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in the treatment of perennial rhinitis for twelve months. Brompton Hospital/Medical Research Council collaborative trial. Clinical Allergy 1980;10(3):239‐51. - PubMed
Berkowitz 1999 {published data only}
    1. Berkowitz RB, Roberson S, Zora J, Capano D, Chen R, Lutz C, Harris AG. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Allergy and Asthma Proceedings 1999;20(3):167‐72. - PubMed
Boner 1994 {published data only}
    1. Boner AL, Sette L. Rhinitis in children: Efficacy and safety of a new intranasal corticosteroid. European Respiratory Review 1994;4(20):271‐3.
Boner 1995 {published data only}
    1. Boner A, Sette L, Martinati L, Sharma RK, Richards DH. The efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitis. Allergy 1995;50(6):498‐505. - PubMed
Cockcroft 1976 {published data only}
    1. Cockcroft DW, MacCormack DW, Newhouse MT, Hargreave FE. Beclomethasone dipropionate aerosol in allergic rhinitis. Canadian Medical Association Journal 1976;115(6):523‐6. - PMC - PubMed
de Graaf Veld 1995 {published data only}
    1. Graaf‐in't Veld C, Garrelds IM, Jansen AP, Toorenenbergen AW, Mulder PG, Meeuwis J, Gerth van Wijk R. Effect of intranasal fluticasone propionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy. Clinical and Experimental Allergy 1995;25(10):966‐73. - PubMed
Dolovich 1990 {published data only}
    1. Dolovich J, Anderson M, Chodirker W, Drouin M, Hargreave FE, Hebert J, Knight A, O'Conner M, Small P, Yang W. Fluticasone propionate: a large multicentre trial. Respiratory Medicine 1990;84(Suppl A):31‐2. - PubMed
Drouin 1996 {published data only}
    1. Drouin M, Yang WH, Bertrand B, Cauwenberge P, Clement P, Dalby K, et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients. Annals of Allergy, Asthma and Immunology 1996;77(2):153‐60. - PubMed
Dunn 1984 {published data only}
    1. Dunn AM, Wilson RS, Baggott PJ. A comparison of beclomethasone dipropionate aqueous nasal spray and beclomethasone dipropionate pressurized nasal spray in the management of seasonal rhinitis. Postgraduate Medical Journal 1984;60(704):404‐6. - PMC - PubMed
Dykewicz 2003 {published data only}
    1. Dykewicz MS, Kaiser HB, Nathan RA, Goode‐Sellers S, Cook CK, Witham LA, Philpot EE, Rickard K. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (PRN). Annals of Allergy, Asthma and Immunology 2003;91(1):44‐8. - PubMed
Fokkens 2002 {published data only}
    1. Fokkens WJ, Cserhati E, dos Santos JM, Praca F, Zanten M, Schade A, Simon G. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Annals of Allergy, Asthma and Immunology 2002;89(3):279‐84. - PubMed
Friedman 1962 {published data only}
    1. Friedman HT. A double blind study of triamcinolone acetonide nasal spray in allergic rhinitis. The Journal of Allergy 1962;33(1):1‐5. - PubMed
Galant 1994 {published data only}
    1. Galant SP, Ahrens RC, Dockhorn RJ, Lumry W, Martin B, Meltzer EO, et al. Treatment of seasonal allergic rhinitis with once‐daily intranasal fluticasone propionate therapy in children. Journal of Pediatrics 1994;125(4):628‐34. - PubMed
Gawchik 2003 {published data only}
    1. Gawchik S, Goldstein S, Prenner B, John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Annals of Allergy, Asthma and Immunology 2003;90(4):416‐21. - PubMed
Girard 1978 {published data only}
    1. Girard JP, Cuevas M, Heimlich EM. A placebo controlled double‐blind trial of beclomethasone dipropionate in the treatment of allergic rhinitis. Allergologia et Immunopathologia (Madrid) 1978;6(2):109‐16. - PubMed
Grossman 1993 {published data only}
    1. Grossman J, Banov C, Bronsky EA, Nathan RA, Pearlman D, Winder JA, et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics 1993;92(4):594‐9. - PubMed
Grubbe 1996 {published data only}
    1. Grubbe R, Adelglass JM, Casale TB, Cohen R, Jacobson KW, Klaustermeyer WB, et al. Intranasal therapy with once‐daily triamcinolone acetonide aerosol versus twice‐daily beclomethasone dipropionate aqueous spray in patients with perennial allergic rhinitis. Current Therapeutic Research Clinical and Experimental 1996;57(11):825‐38.
Gupta 2004 {published data only}
    1. Gupta PP, Gupta KB. Comparative efficacy of once daily mometasone furoate and fluticasone propionate aqueous nasal sprays for the treatment of perennial allergic rhinitis. Indian Journal of Allergy, Asthma and Immunology 2004;18(1):19‐24.
Hebert 1996 {published data only}
    1. Hebert JR, Nolop K, Lutsky BN. Once‐daily mometasone furoate aqueous nasal spray (Nasonex(TM)) in seasonal allergic rhinitis: An active‐ and placebo‐controlled study. Allergy: European Journal of Allergy and Clinical Immunology 1996;51(8):569‐76. - PubMed
Hofman 1995 {published data only}
    1. Hofman J, Trofimowicz A. Introductory clinical evaluation of fluticasone propionate efficacy for treatment of allergic rhinitis in children. Pneumonologia I Alergologia Polska 1995;63:83‐6. - PubMed
Holopainen 1977 {published data only}
    1. Holopainen E, Malmberg H, Tarkiainen E. Experiences of treating allergic rhinitis with intra‐nasal beclomethasone dipropionate. Short‐term trials and long‐term follow‐up. Acta Allergologica 1977;32(4):263‐77. - PubMed
Horan 1978 {published data only}
    1. Horan JD, Johnson JD. Flunisolide nasal spray in the treatment of perennial rhinitis. Canadian Medical Association Journal 1978;119(4):334‐8. - PMC - PubMed
Irander 1984 {published data only}
    1. Irander K, Geterud A, Lindqvist N, Pipkorn U. A single blind clinical comparison between 2 preparations of budesonide in the treatment of seasonal allergic rhinitis. Clinical Otolaryngology and Allied Sciences 1984;9(4):235‐41. - PubMed
Joubert 1983 {published data only}
    1. Joubert JR. Flunisolide nasal spray in the treatment of perennial rhinitis. South African Medical Journal 1983;64(16):623‐4. - PubMed
Kobayashi 1989 {published data only}
    1. Kobayashi RH, Tinkelman DG, Reese ME, Sykes RS, Pakes GE. Beclomethasone dipropionate aqueous nasal spray for seasonal allergic rhinitis in children. Annals of Allergy 1989;62(3):205‐8. - PubMed
McAllen 1980 {published data only}
    1. McAllen MK, Portillo PR, Parr EJ, Seaton A, Engler C. Intranasal flunisolide, placebo and beclomethasone dipropionate in perennial rhinitis. British Journal of Diseases of the Chest 1980;74(1):32‐6. - PubMed
Meltzer 1999 {published data only}
    1. Meltzer EO, Berger WE, Berkowitz RB, Bronsky EA, Dvorin DJ, Finn AF, et al. A dose‐ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology 1999;104(1):107‐14. - PubMed
Moesgaard 1983 {published data only}
    1. Moesgaard‐Nielsen V, Vinther B, Illum P. Grass pollen‐induced hay fever treated with a new steroid fluocortin butylester (FCB). Rhinology 1983;21(3):257‐63. - PubMed
Munch 1982 {published data only}
    1. Munch EP, Weeke B, Johansson SA. The effect of budesonide on nasal allergen challenge in patients with seasonal rhinitis and on nasal peak flow in healthy volunteers. European Journal of Respiratory Diseases 1982;Supplement(122):176‐84. - PubMed
Munk 1994 {published data only}
    1. Munk ZM, Pearlman D, Graft D, Green A, Hampel F, Pleskow W, et al. Intranasal fluticasone propionate is effective and well‐tolerated in adolescents with seasonal allergic rhinitis. Pediatric Asthma, Allergy and Immunology 1994;8(1):39‐46.
Munk 1996 {published data only}
    1. Munk ZM, LaForce C, Furst JA, Simpson B, Feiss G, Smith JA. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology 1996;77(4):277‐81. - PubMed
Ngamphaiboon 1997 {published data only}
    1. Ngamphaiboon J, Thepchatri A, Chatchatee P, Chumdermpadetsuk S. Fluticasone propionate aqueous nasal spray treatment for perennial allergic rhinitis in children. Annals of Allergy, Asthma and Immunology 1997;78(5):479‐84. - PubMed
Nuutinen 1987 {published data only}
    1. Nuutinen J, Ruoppi P, Suonpaa J. One‐dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis. A preliminary report. Rhinology 1987;25(2):121‐7. - PubMed
Pedersen 1991 {published data only}
    1. Pedersen B, Bundgaard Larsen B, Dahl R, Lindqvist N, Mygind N. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis. Allergy 1991;46(8):582‐7. - PubMed
Pedersen 1994 {published data only}
    1. Pedersen B, Larsen BB, Dahl R, Hedbys L, Mygind N. Budesonide powder administration for the treatment of grass‐pollen‐induced allergic rhinitis. Allergy 1994;49(10):855‐60. - PubMed
Pedersen 1995 {published data only}
    1. Pedersen B, Dahl R, Richards DH, Jacques LA, Larsen BB, Pichler W, Nykanen KN. Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis. Allergy 1995;50(10):794‐9. - PubMed
Pedersen 1998 {published data only}
    1. Pedersen W, Hjuler I, Bisgaard H, Mygind N. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy 1998;53(4):383‐7. - PubMed
Pintus 1979 {published data only}
    1. Pintus M. Controlled trial of beclometasone dipropionate spray in allergic rhinitis. Nuovo Archivio Italiano Di Otologia Rinologia E Laringologia 1979;7(2):337‐45.
Pipkorn 1980 {published data only}
    1. Pipkorn U, Rundcrantz H, Lindqvist N. Budesonide ‐ a new nasal steroid. Rhinology 1980;18(4):171‐5. - PubMed
Pipkorn 1982 {published data only}
    1. Pipkorn U, Rundcrantz H. Budesonide and beclomethasone dipropionate in hay fever ‐ a single blind comparison. European Journal of Respiratory Diseases 1982;Supplement(122):211‐20. - PubMed
Pipkorn 1983 {published data only}
    1. Pipkorn U. Hay fever treatment with budesonide and beclomethasone dipropionate twice daily ‐ a clinical comparison. Rhinology 1983;21(4):335‐40. - PubMed
Pipkorn 1984 {published data only}
    1. Pipkorn U, Geteru A. A comparative trial testing budesonide and flunisolide nasal sprays in patients with seasonal allergic rhinitis. Annals of Allergy 1984;52(3):183‐6. - PubMed
Rudolph 1976 {published data only}
    1. Rudolph R, Kunkel G, Staud RD, Koennecke R. The nasal application of beclomethasone diproprionate (Beconase) in allergic rhinitis. Clinical Otolaryngology and Allied Sciences 1976;1(4):315‐23. - PubMed
Rusnak 1981 {published data only}
    1. Rusnak SL. Concurrent administration of flunisolide nasal solution with beclomethasone dipropionate bronchial aerosol in patients with both rhinitis and asthma. Annals of Allergy 1981;47(5 (Pt 1)):320‐4. - PubMed
Scadding 1995 {published data only}
    1. Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo‐controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non‐allergic perennial rhinitis. Clinical and Experimental Allergy 1995;25(8):737‐43. - PubMed
Schulz 1978 {published data only}
    1. Schulz JI, Johnson JD, Freedman SO. Double‐blind trial comparing flunisolide and placebo for the treatment of perennial rhinitis. Clinical Allergy 1978;8(4):313‐20. - PubMed
Shore 1977 {published data only}
    1. Shore SC, Weinberg EG. Beclomethasone dipropionate aerosol in treatment of perennial allergic rhinitis in children. Archives of Disease in Childhood 1977;52(6):486‐8. - PMC - PubMed
Sipila 1983 {published data only}
    1. Sipila P, Sorri M, Ojala K, Palva A. Comparative trial of flunisolide and beclomethasone dipropionate nasal sprays in patients with seasonal allergic rhinitis. Allergy 1983;38(5):303‐7. - PubMed
Spector 1990 {published data only}
    1. Spector S, Bronsky E, Chervinsky P, Lotner G, Koepke J, Selner J, et al. Multicenter, double‐blind, placebo‐controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Annals of Allergy 1990;64(3):300‐5. - PubMed
Steensen 1981 {published data only}
    1. Steensen H, Lindqvist N. Treatment of grass pollen‐induced hay fever with intranasal budesonide. A double‐blind clinical comparison between budesonide and placebo. Allergy 1981;36(4):245‐9. - PubMed
Storms 1996 {published data only}
    1. Storms WW, Southern DL, Feiss G, Simpson B, Furst JA, Smith JA. Efficacy of triamcinolone acetonide aerosol nasal inhaler in children with perennial allergic rhinitis. Pediatric Asthma, Allergy and Immunology 1996;10(2):59‐64.
Strem 1978 {published data only}
    1. Strem EL, Austrian S, Geller GR, Johnson JD, Crepea S. Flunisolide nasal spray for the treatment of children with seasonal allergic rhinitis. Annals of Allergy 1978;41(3):145‐9. - PubMed
Tarlo 1977 {published data only}
    1. Tarlo SM, Cockcroft DW, Dolovich J, Hargreave FE. Beclomethasone dipropionate aerosol in perennial rhinitis. Journal of Allergy and Clinical Immunology 1977;59(3):232‐6. - PubMed
Wahn 1978 {published data only}
    1. Wahn U, Rebien W, Stix E, Wober W. Beclomethasone dipropionate seasonal allergic rhinitis treatment of children. A double blind cross over study. Monatsschr‐Kinderheilkd 1978;126(3):133‐5. - PubMed
Warland 1981 {published data only}
    1. Warland A, Moller P, Lindqvist N. Budesonide ‐ a new steroid for intranasal use. A double‐blind clinical comparison between budesonide and placebo in patients with seasonal allergic rhinitis. Allergy 1981;36(6):425‐8. - PubMed
Warland 1982 {published data only}
    1. Warland A. Evaluation of flunisolide nasal solution in the symptomatic treatment of perennial rhinitis. Allergy 1982;36(6):425‐8. - PubMed
Welch 1991 {published data only}
    1. Welch MJ, Bronsky EA, Grossman J, Shapiro GG, Tinkelman DG, Garcia JD, Gillen MS. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Annals of Allergy 1991;67(5):493‐8. - PubMed
Welch 1994 {published data only}
    1. Welch MJ, Bronsky E, Findlay S, Pearlman DS, Southern DL, Storms WW, Weakley S. Long‐term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clinical Therapeutics 1994;16(2):253‐62. - PubMed
Yang 1998 {published data only}
    1. Yang WH, Dolovich J, Drouin MA, Keith P, Haddon J, Jennings B, et al. Comparison of budesonide Turbuhaler with budesonide aqua in the treatment of seasonal allergic rhinitis. Canadian Respiratory Journal 1998;5(6):455‐60. - PubMed
Zhang 1995 {published data only}
    1. Zhang H, Wang L, Yu F, Yi J, Wu Z. A double‐blind parallel group study of beclomethasone dipropoinate nasal spray of two different sources in the treatment of allergic rhinitis. Acta Academiae Medicinae Sinicae (Zhongguo Yi Xue Ke Xue Yuan Xue Bao) 1995;17(5):375‐8. - PubMed

References to studies awaiting assessment

Aasand 1982 {published data only}
    1. Aasand G, Etholm BO, Skjostad M, Volden J. Flunisolide nasal spray compared to beclomethasone dipropionate in the treatment of seasonal rhinitis. Rhinology 1982;20(4):205‐11. - PubMed
Banov 1996 {published data only}
    1. Banov CH, Silvers WS, Green AW, Bavel JH, Winder JA, Feiss G, et al. Placebo‐controlled, double‐blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clinical Therapeutics 1996;18(2):265‐72. - PubMed
Becher 1994 {published data only}
    1. Becher G, Beck E, Schmidtke J, Hummel ST. Treatment by fluticasone propionate (FP) 200µg in patients with allergic rhinitis in a placebo controlled double blind study with cross over design. European Respiratory Journal 1994;7(Suppl 18):32s.
Dash 1984 {published data only}
    1. Dash CH, Beggott PJ, Haydock A, Pover GM, Sidwell S. New preparation of beclomethasone dipropionate (BDP) for intranasal use: A double‐blind comparative trial in seasonal rhinitis. American Lung Association, American Thoracic Society and Congress of Lung Association Staff Annual Meeting 1984.
Erin 2003 {published data only}
    1. Erin EM, Hau Y, Nicholson G, Jose P, Williams T, Boyce M, et al. A double‐blind placebo‐controlled randomised 4‐way crossover single dose study to assess the effects of budesonide upon nasal allergen challenge‐induced inflammation in patients with grass pollen allergic rhinitis out of season. American Thoracic Society 99th International Conference A105 Poster D39 2003.
Gale 1980 {published data only}
    1. Gale AE, Solomon E, Tao BS. Intranasal topical flunisolide therapy in children with seasonal allergic rhinitis. Clinical Allergy 1980;10(5):527‐33. - PubMed
Gorski 2000 {published data only}
    1. Gorski P, Bochenska‐Marciniak M, Walusiak J, Palczynski C, Kuna P. Clinical efficacy of intranasal mometasone furoate aqueous nasal spray, once daily in patients with perennial allergic rhinitis. XVII International Congress of Allergology and Clinical Immunology (ICACI) Abstract No. P‐586 2000.
Holmstrom 1999 {published data only}
    1. Holmstrom M. Clinical performance of fluticasone propionate nasal drops. Allergy 1999;54(Suppl 53):21‐5. - PubMed
McGivern 1985 {published data only}
    1. McGivern DV, Basran GS, Handley S, Davies D. A comparison of budesonide and beclomethasone dipropriate in perennial rhinitis. European Academy of Allergy and Clinical Immunology 1985;239:215.
Okuda 1986 {published data only}
    1. Okuda M, Okamoto M, Nomura Y, Saito Y. Clinical study on beclomethasone dipropionate powder preparation (TL‐102) in perennial nasal allergy. Rhinology 1986;24(2):113‐23. - PubMed
Schenkel 1997 {published data only}
    1. Schenkel EJ, Gross G, Jacobson K, Kobayashi R, Settipane G, Savacool AM, Simpson BE, Smith JA. Triamcinolone acetonide aqueous nasal inhaler for the treatment of spring grass seasonal allergic rhinitis in children. Pediatric Asthma, Allergy and Immunology 1997;11(2):129‐36.
Stern 1994 {published data only}
    1. Stern MA, Harris P, Dahl R, Larsen BB, Nielsen LP, Pedersen B, et al. A placebo controlled study comparing budesonide 256 µg and 128 µg with fluticasone propionate 200 µg in patients with seasonal allergic rhinitis. European Respiratory Journal 1994;7(Suppl 18):31s.
Turkeltaub 1976 {published data only}
    1. Turkeltaub PC, Norman PS, Crepea S. Treatment of ragweed hay fever with an intranasal spray containing fluinsolide, a new synthetic corticosteroid. Journal of Allergy and Clinical Immunology 1976;58(5):597‐606. - PubMed
Turkeltaub 1982 {published data only}
    1. Turkeltaub PC, Norman PS, Johnson JD, Crepea S. Treatment of seasonal and perennial rhinitis with intranasal flunisolide. Allergy 1982;37(5):303‐11. - PubMed

Additional references

AHRQ 2002
    1. Management of Allergic and Nonallergic Rhinitis. Summary, Evidence Report/Technology Assessment. Agency for Healthcare Research and Quality, U.S. Department of Health and Human Sciences. Rockville, Md, 2002, issue 54.
ARIA 2001
    1. Bousquet J, Cauwenberge P, Khaltaev N. Allergic Rhinitis and its Impact on Asthma (ARIA). Journal of Allergy and Clinical Immunology 2001;108(5 suppl):S147‐S336. - PubMed
Bircher 1996
    1. Bircher AJ, Pelloni F, Muller D. Delayed hypersensitivity reaction to corticosteroids applied to mucous membranes. British Journal of Dermatology 1996;135:310‐3. - PubMed
Bousquet 1994
    1. Bousquet J, Bullinger M, Fazol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis. Journal of Allergy and Clinical Immunology 1994;94(2.1):182‐8. - PubMed
Clarke 2003
    1. Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]. In: The Cochrane Library, Issue 2, 2003. The Cochrane Collaboration. Chichester: John Wiley and Sons Ltd.
Fireman 2000
    1. Fireman P. Therapeutic approaches to allergic rhinitis: Treating the child. Journal of Allergy and Clinical Immunology 2000;105:616‐21. - PubMed
Gazis 1999
    1. Gazis AG, Homer JJ, Henson DB, Jones NS. The effect of six weeks of topical betamethasone drops on the hypothalamo‐pituitary‐adrenal axis and bone turnover in patients with nasal polyposis. Clinical Otolaryngology 1999;24(6):495‐8. - PubMed
Gelfand 2005
    1. Gelfand EW. Pediatric allergic rhinitis: factors affecting treatment choice. Ear, Nose and Throat Journal 2005;84(3):163‐8. - PubMed
Johansson 1997
    1. Johansson SG. The discovery of IgE and its importance for allergologists. Nordisk medicin 1997;112(4):115‐8. - PubMed
LaForce 1985
    1. LaForce C, DavisV. Nasal perforation in patients using intranasal beclomethasone diproprionate (BDP). Journal of Allergy and Clinical Immunology 1985;75(S):186.
Ledford 1998
    1. Ledford DK, Lockey RF. Allergic rhinitis. Journal of Respiratory Disease 1998;19(7):576‐84.
Long 2002
    1. Long A, McFadden C, DeVine D, Chew P, Kupelnick B, Lau J. Management of allergic and nonallergic rhinitis. Agency for Healthcare Research and Quality, Rockville, MD, USA 2002; Vol. 198. - PMC - PubMed
Meltzer 2001
    1. Meltzer EO. Quality of life in adults and children with allergic rhinitis. Journal of Allergy and Clinical Immunology 2001;108(5 suppl):S45‐53. - PubMed
Michels 1967
    1. Michels MI, Smith RE, Heimlich EM. Adrenal supression and intranasally applied steroids. Annals of Allergy 1967;25:569‐74. - PubMed
Naclerio 1993
    1. Naclerio RM, Mygind M. Intranasal steroids. Philadelphia: Mygind N, Naclerio RM, editors, 1993.
Nash 2000
    1. Nash DB, Sullivan SD, Mackowiak J. Optimizing quality of care and cost effectiviness in treating allergic rhinitis in a managed care setting. American Journal of Managed Care 2000;6(S1):3‐15. - PubMed
Norman 1967
    1. Norman PS, Winkenwerder WL, Agbayani BF, Migeon CJ. Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever. Journal of Allergy 1967;40:57‐61. - PubMed
Rak 1994
    1. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clinical and Experimental Allergy 1994;24:930‐9. - PubMed
Santos 1999
    1. Santos R, Cifaldi M, Gregory C, Seitz P. Economic outcomes of a targeted intervention program: the costs of treatment of allergic rhinitis patients. American Journal of Managed Care 1999;5(S4):225‐34. - PubMed
Sheikh 2007
    1. Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database of Systematic Reviews 2007, Issue 1. - PubMed
Skoner 2000
    1. Skoner D, Rachelefsky G, Meltzer E, et al. Detection of growth supression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105(2):E23. - PubMed
Spector 1997
    1. Spector SL. Overview of comorbid association of allergic rhinitis. Journal of Allergy and Clinical Immunology 1997;99:S773‐80. - PubMed
Spector 1999
    1. Spector SL. Pathophysiology and pharmacotherapy of allergic rhinitis. Journal of Allergy and Clinical Immunology 1999;103(3 pt 2):S377. - PubMed
van Cauwenberge 2000
    1. Cauwenberge P, Bachert C, Passalaqua G, Bousquet J, Canonica GW, Durham SR, et al. Consensus statement on the treatment of allergy rhinitis. Allergy 2000;55(2):116‐34. - PubMed
Waddell 2003
    1. Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?. The Journal of Laryngology and Otology 2003;117:843‐5. - PubMed
Weiner 1998
    1. Weiner J, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624‐9. - PMC - PubMed
Yanez 2002
    1. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta‐analysis. Annals of Allergy, Asthma and Immunology 2002;89(5):479‐84. - PubMed

Publication types

MeSH terms

Substances